Income statement of RESMED INC, period by period
The same statement from the last 4 quarterly reports (10-Q), one column per filing, newest first. Each number is the filing's own text and each column links to the filing it was read from. Lines that one period has and another does not are marked. Nothing is recalculated.
Income statement 34 lines
2 lines added, 7 dropped and 5 reworded between these periods. 7 numbers shown differently by a later filing (marked “Revised”; the cell keeps the first-reported figure and the badge opens the later filing). Amounts in thousands, except per share.
| Line item | Sep 30, 2026
10-Q · 3 months | Mar 31, 2026
10-Q · 3 months | Dec 31, 2025
10-Q · 3 months | Sep 30, 2025
10-Q · 3 months |
|---|---|---|---|---|
| Net revenue - Sleep and Breathing Health products | $1,259,802 | $1,260,516 | $1,255,938 | $1,169,446 |
| Net revenue - Residential Care Software | 155,012 | 170,890 | 166,870 | 166,136 |
| Net revenue | 1,414,814 | 1,431,406 | 1,422,808 | 1,335,582 |
| Cost of sales - Sleep and Breathing Health products | 493,879 | 481,722 | 484,792 | 456,118 Revised |
| Cost of sales - Residential Care Software | 50,368 | 50,855 | 51,484 | 50,823 Revised |
| Cost of sales (exclusive of amortization shown separately below) Dropped | · | 532,577 | 536,276 | 506,941 |
| Amortization of acquired intangible assets - Sleep and Breathing Health products Dropped | · | 1,421 | 1,415 | 1,420 |
| Amortization of acquired intangible assets - Residential Care Software Dropped | · | 6,429 | 6,393 | 6,401 |
| Amortization of acquired intangible assets Dropped | · | 7,850 | 7,808 | 7,821 |
| Total cost of sales | 544,247 | 540,427 | 544,084 | 514,762 Revised |
| Gross profit | 870,567 | 890,979 | 878,724 | 820,820 Revised |
| Operating expenses | ||||
| Research and development | 102,860 | 94,267 | 90,969 | 87,323 Revised |
| Amortization of acquired intangible assets Dropped | · | 11,247 | 11,764 | 11,956 |
| Restructuring expenses (note 11) Dropped | · | — | 5,935 | 15,810 |
| Selling, general, and administrative | 314,723 | 285,655 | 278,396 | 259,194 Revised |
| Total operating expenses | 417,583 | 391,169 | 387,064 | 374,283 Revised |
| Income from operations | 452,984 | 499,810 | 491,660 | 446,537 |
| Other income (loss), net | ||||
| Interest income Reworded | 21,198 | 12,287 | 7,949 | 8,793 |
| Interest expense Added | (4,814) | · | · | · |
| Gain (loss) attributable to equity method investments Reworded | 1,884 | 1,718 | 1,515 | 1,489 |
| Gain (loss) on equity investments Reworded | 5,719 | (10,130) | 306 | (6,190) |
| Gain on divestment of subsidiaries Added | 61,784 | · | · | · |
| Other, net | 400 | (1,373) | (5,282) | (3,836) |
| Total other income (loss), net | 86,171 | 2,502 | 4,488 | 256 |
| Income before income taxes | 539,155 | 502,312 | 496,148 | 446,793 |
| Income taxes | 120,742 | 103,580 | 103,555 | 98,257 |
| Net income | $418,413 | $398,732 | $392,593 | $348,536 |
| Dividend declared per share Dropped | · | $0.60 | $0.60 | $0.60 |
| Basic earnings per share Reworded | $2.93 | $2.74 | $2.69 | $2.38 |
| Diluted earnings per share Reworded | $2.92 | $2.74 | $2.68 | $2.37 |
| Basic shares outstanding (000's) | 142,989 | 145,340 | 145,842 | 146,182 |
| Diluted shares outstanding (000's) | 143,411 | 145,723 | 146,372 | 146,899 |
“·” means the filing's statement has no such line. A line whose wording changed only in its profit/loss sign (“Net loss”, “Net income (loss)”) is kept on one row; hover the name to see the other wordings. A line dropped in one period and a similarly worded one added in the next is joined on one row marked “Reworded”; check the note before relying on it. Columns of a cash flow statement cover the months the filing says (a quarterly report adds the quarters of the year so far).